FLXN Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 saus. 1970 @ 03:00):

Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of patients with musculoskeletal conditions...

Stats
Šios dienos apimtis	0
Vidutinė apimtis	2.17M
Rinkos kapitalizacija	0.00
EPS	$-0.600 ( Q3 \| 2021-11-12 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 0
ATR14	$0.321 (3.52%)

ACOR -24.02%

ACRX 7.50%

ADMP 0.85%

ADMS 0.00%

AGRX -1.40%

AKAN -3.75%

ALIM 0.54%

AMPH -0.87%

AMYT 0.00%

ANIP 0.94%

AQST 0.39%

ASRT -5.34%

ATNX 0.00%

AVDL -1.75%

AYTU 0.00%

BFRI -2.39%

BGXX -34.22%

CLVR -2.22%

COLL -0.74%

CPIX 0.66%

CRDL 1.00%

CRON -0.43%

CYTH 5.83%

DCPH 0.00%

DERM 9.73%

DRRX -5.49%

DVAX -1.23%

EGRX 11.55%

EMBC 0.32%

EMBCV -9.33%

EOLS -0.73%

ESPR -3.90%

EVOK 5.48%

FLGC 6.71%

FLXN 0.00%

GHSI -0.35%

HCM -1.83%

HROW -0.52%

HUGE -4.71%

IMCC 2.20%

INCR 2.03%

IRWD 5.16%

ITCI -3.51%

IXHL 10.53%

JUPW 11.76%

KALA 9.92%

KIN 0.11%

KMDA -1.78%

LNTH -1.25%

NBIX 2.50%

NEPT 0.00%

NLTX 1.45%

OGI -3.75%

OPTN -3.70%

ORGO 6.06%

PAHC -2.50%

PCRX 2.51%

PETQ -0.45%

PLXP 0.00%

PPD 0.00%

PROC -0.40%

PRPH -2.11%

PTPI 2.69%

RDHL -2.58%

RDUS 4.30%

REPH -0.48%

RGC -5.88%

RMTI 0.00%

SCTL 0.92%

SCYX -1.48%

SIGA 3.13%

SISI -13.33%

SNDL -1.04%

SNOA 1.05%

SSIC 1.03%

SUPN -0.45%

SXTC -2.24%

THTX 0.00%

TKNO -1.44%

TLGT -13.85%

TLRY -4.05%

TXMD -7.47%

TYHT -3.90%

UPC -1.97%

VTRS 1.43%

ZYNE 2.36%

Insider Trading

Date	Person	Action	Amount	type
2021-11-19	Newtyn Management, Llc	Sell	5 900 000	Common Stock, par value $0.001 per share
2021-11-18	Newtyn Management, Llc	Buy	0	Common Stock, par value $0.001 per share
2021-11-19	Stejbach Mark	Sell	12 631	Common Stock
2021-11-19	Stejbach Mark	Sell	25 000	Stock option (right to buy)
2021-11-19	Stejbach Mark	Sell	12 500	Stock option (right to buy)

INSIDER POWER
0.00
Last 99 transactions
Buy: 271 750 \| Sell: 9 779 666

Tūris Koreliacija

Ilgas: 0.20 (neutral)

Trumpas: -0.90 (strong negative)

Signal:(61.022) Neutral

Flexion Therapeutics Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
ADMS	0.925
ICON	0.857
BRKS	0.847
TYHT	0.841
RMRM	0.836
CNBKA	0.835
DCRCU	0.832
LMRKO	0.818
DRNA	0.804

10 Labiausiai neigiamai susiję koreliacijos
ASRVP	-0.825

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Flexion Therapeutics Inc Koreliacija - Valiuta/Žaliavos

-0.31
( neutral )

0.47
( neutral )

0.26
( neutral )

-0.72
( moderate negative )

-0.44
( neutral )

0.08
( neutral )

Flexion Therapeutics Inc Finansinės ataskaitos

Annual	2020
Pajamos:	$85.55M
Bruto pelnas:	$66.30M (77.50 %)
EPS:	$-2.53

FY	2020
Pajamos:	$85.55M
Bruto pelnas:	$66.30M (77.50 %)
EPS:	$-2.53

FY	2019
Pajamos:	$72.96M
Bruto pelnas:	$63.00M (86.35 %)
EPS:	$-3.93

FY	2018
Pajamos:	$22.52M
Bruto pelnas:	$15.19M (67.43 %)
EPS:	$-4.49

Financial Reports:

No articles found.

Flexion Therapeutics Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Flexion Therapeutics Inc

Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of patients with musculoskeletal conditions. It offers ZILRETTA, an intra-articular injection for the management of osteoarthritis (OA) pain of the knee in the United States. The company also develops FX201, a gene therapy product candidate designed to stimulate the production of an anti-inflammatory protein, interleukin-1 receptor antagonist for pain relief from OA of the knee; and FX301, an administered NaV1.7 inhibitor for the management of post-operative pain. Flexion Therapeutics, Inc. was founded in 2007 and is headquartered in Burlington, Massachusetts.